nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Skin necrosis—Carmustine—melanoma	0.0399	0.132	CcSEcCtD
Dobutamine—Skin exfoliation—Bleomycin—melanoma	0.0152	0.0505	CcSEcCtD
Dobutamine—Phlebitis—Bleomycin—melanoma	0.0135	0.0446	CcSEcCtD
Dobutamine—Skin exfoliation—Carmustine—melanoma	0.0133	0.0441	CcSEcCtD
Dobutamine—Skin exfoliation—Temozolomide—melanoma	0.0129	0.0426	CcSEcCtD
Dobutamine—Phlebitis—Dactinomycin—melanoma	0.0126	0.0416	CcSEcCtD
Dobutamine—Phlebitis—Carmustine—melanoma	0.0117	0.0389	CcSEcCtD
Dobutamine—Hypokalaemia—Carmustine—melanoma	0.00921	0.0305	CcSEcCtD
Dobutamine—Hypokalaemia—Temozolomide—melanoma	0.0089	0.0295	CcSEcCtD
Dobutamine—Hypotension—Vemurafenib—melanoma	0.00879	0.0291	CcSEcCtD
Dobutamine—Skin exfoliation—Docetaxel—melanoma	0.00855	0.0283	CcSEcCtD
Dobutamine—Phlebitis—Docetaxel—melanoma	0.00755	0.025	CcSEcCtD
Dobutamine—Pruritus—Vemurafenib—melanoma	0.00665	0.022	CcSEcCtD
Dobutamine—Chest pain—Bleomycin—melanoma	0.00594	0.0197	CcSEcCtD
Dobutamine—Headache—Vemurafenib—melanoma	0.00589	0.0195	CcSEcCtD
Dobutamine—Nausea—Vemurafenib—melanoma	0.00559	0.0185	CcSEcCtD
Dobutamine—Thrombocytopenia—Bleomycin—melanoma	0.00558	0.0185	CcSEcCtD
Dobutamine—Angina pectoris—Docetaxel—melanoma	0.00548	0.0181	CcSEcCtD
Dobutamine—Hypotension—Bleomycin—melanoma	0.00532	0.0176	CcSEcCtD
Dobutamine—Palpitations—Temozolomide—melanoma	0.0052	0.0172	CcSEcCtD
Dobutamine—Thrombocytopenia—Dactinomycin—melanoma	0.0052	0.0172	CcSEcCtD
Dobutamine—Chest pain—Carmustine—melanoma	0.00519	0.0172	CcSEcCtD
Dobutamine—Dyspnoea—Bleomycin—melanoma	0.00508	0.0168	CcSEcCtD
Dobutamine—Thrombocytopenia—Carmustine—melanoma	0.00487	0.0161	CcSEcCtD
Dobutamine—Tachycardia—Carmustine—melanoma	0.00485	0.0161	CcSEcCtD
Dobutamine—Thrombocytopenia—Temozolomide—melanoma	0.00471	0.0156	CcSEcCtD
Dobutamine—Hypotension—Carmustine—melanoma	0.00465	0.0154	CcSEcCtD
Dobutamine—Dyspnoea—Carmustine—melanoma	0.00443	0.0147	CcSEcCtD
Dobutamine—Dyspnoea—Temozolomide—melanoma	0.00429	0.0142	CcSEcCtD
Dobutamine—Pruritus—Bleomycin—melanoma	0.00403	0.0134	CcSEcCtD
Dobutamine—Palpitations—Docetaxel—melanoma	0.00346	0.0115	CcSEcCtD
Dobutamine—Pruritus—Temozolomide—melanoma	0.0034	0.0113	CcSEcCtD
Dobutamine—Nausea—Bleomycin—melanoma	0.00338	0.0112	CcSEcCtD
Dobutamine—Chest pain—Docetaxel—melanoma	0.00333	0.011	CcSEcCtD
Dobutamine—Nausea—Dactinomycin—melanoma	0.00316	0.0105	CcSEcCtD
Dobutamine—Thrombocytopenia—Docetaxel—melanoma	0.00313	0.0104	CcSEcCtD
Dobutamine—Tachycardia—Docetaxel—melanoma	0.00312	0.0103	CcSEcCtD
Dobutamine—Headache—Carmustine—melanoma	0.00312	0.0103	CcSEcCtD
Dobutamine—Headache—Temozolomide—melanoma	0.00301	0.00997	CcSEcCtD
Dobutamine—Hypotension—Docetaxel—melanoma	0.00299	0.00989	CcSEcCtD
Dobutamine—Nausea—Carmustine—melanoma	0.00295	0.00978	CcSEcCtD
Dobutamine—Nausea—Temozolomide—melanoma	0.00286	0.00946	CcSEcCtD
Dobutamine—Dyspnoea—Docetaxel—melanoma	0.00285	0.00944	CcSEcCtD
Dobutamine—Pruritus—Docetaxel—melanoma	0.00226	0.00749	CcSEcCtD
Dobutamine—Headache—Docetaxel—melanoma	0.002	0.00663	CcSEcCtD
Dobutamine—Nausea—Docetaxel—melanoma	0.0019	0.00629	CcSEcCtD
Dobutamine—COMT—Metabolism—PRKCA—melanoma	0.000379	0.000543	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM1—melanoma	0.000377	0.00054	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR7—melanoma	0.000377	0.00054	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ERCC2—melanoma	0.000376	0.000539	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SUFU—melanoma	0.000375	0.000538	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SUFU—melanoma	0.000367	0.000526	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT3—melanoma	0.000361	0.000517	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTEN—melanoma	0.000355	0.000509	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CG—melanoma	0.000355	0.000508	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT3—melanoma	0.000353	0.000505	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RHOB—melanoma	0.00035	0.000502	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BCL2L11—melanoma	0.00035	0.000502	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BCL2L11—melanoma	0.000343	0.000491	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RHOB—melanoma	0.000343	0.000491	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—melanoma	0.000342	0.00049	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HDAC6—melanoma	0.000337	0.000482	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—EDN1—melanoma	0.000334	0.000478	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTEN—melanoma	0.000331	0.000475	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HDAC6—melanoma	0.000329	0.000472	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—EDN1—melanoma	0.000326	0.000467	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CSF2—melanoma	0.000326	0.000467	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCR2—melanoma	0.000319	0.000457	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CXCL8—melanoma	0.000319	0.000457	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CSF2—melanoma	0.000319	0.000457	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAC2—melanoma	0.000314	0.00045	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCA—melanoma	0.000313	0.000448	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCR2—melanoma	0.000312	0.000447	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—melanoma	0.000312	0.000447	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CD—melanoma	0.000312	0.000447	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—WNT5A—melanoma	0.000309	0.000443	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFC—melanoma	0.000309	0.000443	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—melanoma	0.000308	0.000441	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAC2—melanoma	0.000307	0.00044	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCA—melanoma	0.000306	0.000438	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDN1—melanoma	0.000303	0.000434	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—WNT5A—melanoma	0.000302	0.000433	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFC—melanoma	0.000302	0.000433	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CG—melanoma	0.000297	0.000426	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDN1—melanoma	0.000296	0.000425	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CSF2—melanoma	0.000296	0.000424	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—RAC1—melanoma	0.00029	0.000415	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CSF2—melanoma	0.00029	0.000415	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—melanoma	0.000287	0.000411	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCA—melanoma	0.000284	0.000407	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.000283	0.000406	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000278	0.000398	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAP2K2—melanoma	0.000278	0.000398	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CB—melanoma	0.000272	0.000389	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000271	0.000389	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2R—melanoma	0.000271	0.000389	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—melanoma	0.000269	0.000386	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2R—melanoma	0.000266	0.00038	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RAC1—melanoma	0.000263	0.000377	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRB—melanoma	0.000263	0.000377	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CD—melanoma	0.000261	0.000374	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—melanoma	0.000258	0.000369	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000257	0.000369	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000257	0.000368	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTK2B—melanoma	0.000255	0.000366	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—melanoma	0.00025	0.000359	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTK2B—melanoma	0.00025	0.000358	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAB2—melanoma	0.000248	0.000356	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNA11—melanoma	0.000248	0.000356	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FLT1—melanoma	0.000247	0.000354	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	0.000245	0.000351	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNA11—melanoma	0.000243	0.000348	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAB2—melanoma	0.000243	0.000348	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FLT1—melanoma	0.000242	0.000346	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	0.00024	0.000343	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTEN—melanoma	0.000235	0.000336	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—melanoma	0.000234	0.000335	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCR4—melanoma	0.000233	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HDAC2—melanoma	0.000233	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FOXO4—melanoma	0.000233	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNAQ—melanoma	0.000231	0.000331	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HDAC2—melanoma	0.000228	0.000327	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FOXO4—melanoma	0.000228	0.000327	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCR4—melanoma	0.000228	0.000327	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CB—melanoma	0.000228	0.000326	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNAQ—melanoma	0.000226	0.000323	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—melanoma	0.000226	0.000323	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—melanoma	0.000222	0.000319	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—melanoma	0.000218	0.000312	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SYK—melanoma	0.000217	0.000311	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	0.000215	0.000308	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT3—melanoma	0.000213	0.000305	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGFR—melanoma	0.000213	0.000305	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ITGAV—melanoma	0.000213	0.000305	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SYK—melanoma	0.000212	0.000304	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	0.000211	0.000302	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT3—melanoma	0.000208	0.000298	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGFR—melanoma	0.000208	0.000298	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ITGAV—melanoma	0.000208	0.000298	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—melanoma	0.000205	0.000293	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOCS1—melanoma	0.000197	0.000283	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAP2K1—melanoma	0.000197	0.000282	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTEN—melanoma	0.000197	0.000282	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—S100B—melanoma	0.000197	0.000282	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CD—melanoma	0.000195	0.00028	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000193	0.000276	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000192	0.000276	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—S100B—melanoma	0.000192	0.000276	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.000191	0.000274	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—melanoma	0.000191	0.000274	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB4—melanoma	0.000188	0.00027	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	0.000188	0.000269	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN2B—melanoma	0.000186	0.000267	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000184	0.000264	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000184	0.000263	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.000182	0.000261	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CD86—melanoma	0.00018	0.000258	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—melanoma	0.00018	0.000258	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDN1—melanoma	0.000179	0.000256	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CD86—melanoma	0.000176	0.000253	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.000176	0.000253	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDN1—melanoma	0.000175	0.000251	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CSF2—melanoma	0.000175	0.000251	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF1—melanoma	0.000175	0.000251	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IL2—melanoma	0.000172	0.000247	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—E2F1—melanoma	0.000171	0.000245	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CSF2—melanoma	0.000171	0.000245	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF1—melanoma	0.000171	0.000245	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CB—melanoma	0.00017	0.000244	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDGFRA—melanoma	0.000169	0.000243	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IL2—melanoma	0.000169	0.000241	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ITGB3—melanoma	0.000168	0.00024	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCA—melanoma	0.000168	0.00024	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—E2F1—melanoma	0.000167	0.00024	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000167	0.000239	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.000166	0.000237	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—melanoma	0.000166	0.000237	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—melanoma	0.000164	0.000236	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000164	0.000235	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000164	0.000235	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000164	0.000235	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000164	0.000235	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—melanoma	0.000161	0.00023	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.00016	0.00023	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.00016	0.000229	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL2—melanoma	0.000156	0.000224	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—melanoma	0.000156	0.000223	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAC1—melanoma	0.000155	0.000223	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL2—melanoma	0.000153	0.000219	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—melanoma	0.000153	0.000218	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAC1—melanoma	0.000152	0.000218	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—melanoma	0.000149	0.000214	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—melanoma	0.000146	0.000209	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—melanoma	0.000143	0.000204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—melanoma	0.000139	0.0002	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—melanoma	0.000139	0.000199	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FN1—melanoma	0.000137	0.000197	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—melanoma	0.000135	0.000194	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH1—melanoma	0.000134	0.000192	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FN1—melanoma	0.000134	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CD80—melanoma	0.000132	0.000189	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000131	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—melanoma	0.000131	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KIT—melanoma	0.000131	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—melanoma	0.000131	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NRAS—melanoma	0.000131	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGF—melanoma	0.00013	0.000186	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CD80—melanoma	0.000129	0.000184	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KIT—melanoma	0.000128	0.000184	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.000128	0.000184	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—melanoma	0.000128	0.000184	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NRAS—melanoma	0.000128	0.000184	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGF—melanoma	0.000127	0.000182	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK3—melanoma	0.000126	0.00018	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—melanoma	0.000123	0.000177	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000123	0.000176	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—melanoma	0.000121	0.000173	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—melanoma	0.00012	0.000172	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK1—melanoma	0.00012	0.000171	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—melanoma	0.00012	0.000171	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—melanoma	0.000118	0.000169	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000117	0.000168	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000117	0.000168	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAP2K1—melanoma	0.000116	0.000167	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CD—melanoma	0.000115	0.000165	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	0.000114	0.000164	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000114	0.000163	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—melanoma	0.000113	0.000162	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—melanoma	0.000113	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000113	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000112	0.00016	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—melanoma	0.000111	0.000158	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF2—melanoma	0.000111	0.000158	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF2—melanoma	0.000108	0.000155	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—melanoma	0.000104	0.000149	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MDM2—melanoma	0.000103	0.000148	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB2—melanoma	0.000102	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—melanoma	0.000102	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MDM2—melanoma	0.000101	0.000145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CB—melanoma	0.000101	0.000144	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB2—melanoma	9.98e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CB—melanoma	9.85e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—melanoma	9.67e-05	0.000139	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—melanoma	9.61e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—melanoma	9.46e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1B—melanoma	9.45e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—melanoma	9.4e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—melanoma	9.34e-05	0.000134	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—melanoma	9.26e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL2—melanoma	9.24e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1B—melanoma	9.24e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—melanoma	9.2e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—melanoma	9.14e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—melanoma	9.06e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL2—melanoma	9.04e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—melanoma	9.01e-05	0.000129	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—melanoma	9e-05	0.000129	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—melanoma	8.92e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—melanoma	8.81e-05	0.000126	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—melanoma	8.75e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—melanoma	8.73e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1A—melanoma	8.72e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTEN—melanoma	8.7e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKB1—melanoma	8.66e-05	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—melanoma	8.56e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1A—melanoma	8.53e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTEN—melanoma	8.51e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—melanoma	8.48e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKB1—melanoma	8.47e-05	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—melanoma	8.3e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—melanoma	7.86e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—melanoma	7.78e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRAS—melanoma	7.76e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—melanoma	7.68e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—melanoma	7.61e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRAS—melanoma	7.59e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK3—melanoma	7.43e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK3—melanoma	7.27e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—melanoma	7.23e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK1—melanoma	7.07e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—melanoma	7.07e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—melanoma	7.07e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK1—melanoma	6.92e-05	9.91e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—melanoma	6.92e-05	9.91e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—melanoma	6.68e-05	9.57e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—melanoma	6.53e-05	9.36e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.14e-05	8.79e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—melanoma	6e-05	8.6e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—melanoma	5.94e-05	8.5e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—melanoma	5.81e-05	8.32e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—melanoma	5.68e-05	8.13e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—melanoma	5.55e-05	7.95e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—melanoma	5.43e-05	7.78e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—melanoma	5.31e-05	7.61e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—melanoma	5.01e-05	7.18e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—melanoma	4.9e-05	7.02e-05	CbGpPWpGaD
